Julie Jordan
CIK: 0001968554
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (33.3%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NGNE
Neurogene Inc.
Officer
Discretionary Trading P&L
Holdings
About Jordan Julie
Jordan Julie (SEC CIK 0001968554) files insider reports with the SEC as Chief Medical Officer of Neurogene Inc. (NGNE).
Signal8 holds 3 ownership filings by Jordan Julie, all Form 4s, filed between Mar 28, 2025 and Mar 30, 2026. Those filings report 3 transactions, from Mar 26, 2025 to Mar 26, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Jordan Julie's filings is in NEW YORK, NY.
Recent filings by Jordan Julie
Other insiders filing for Neurogene Inc. (NGNE)
- McMinn Rachel, Chief Executive Officer
- Cvijic Christine Mikail, President and CFO
- Woods Keith, Director
- Shafer Christina, Chief Commercial Officer
- Cobb Stuart, Chief Scientific Officer
- PALEKAR ROHAN, Director